Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Antineoplastic agents (Organometallic).php on line 2
Antineoplastic agents (Organometallic)
LE WE PMID CA
Antineoplastic agents (Organometallic)12510Antineoplastische Substanz (Organometallisch)

Antineoplastic agents (Organometallic)

Antineoplastic agents (Resistance)

Cisplatin

Drug delivery

Selen

SERM

2011  
1
Organometallic anticancer compounds.
[21077686] J Med Chem 54(1): 3-25 (2011)
2009  
2
Novel strategies for reversing platinum resistance.
[19805003] Drug Resist Updat 12(6): 148-52 (2009)
2007  
3
Molecular mechanisms of resistance and toxicity associated with platinating agents.
[17084534] Cancer Treat Rev 33(1): 9-23 (2007)
2010  
4
Specific hemosiderin deposition in spleen induced by a low dose of cisplatin: altered iron metabolism and its implication as an acute hemosiderin formation model.
[20540689] Curr Drug Metab 11(6): 507-15 (2010)
2010  
5
Role of glutathione in the regulation of Cisplatin resistance in cancer chemotherapy.
[20885916] Met Based Drugs 2010(-): - (2010)
2010  
6
Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review.
[20886011] Met Based Drugs 2010(-): - (2010)
2005  
7
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes.
[16193110] Chem Commun (Camb) -(38): 4764-76 (2005)
2009  
8
Unusual DNA binding modes for metal anticancer complexes.
[19344743] Biochimie 91(10): 1198-211 (2009)
2010  
9
Targeting selenium metabolism and selenoproteins: novel avenues for drug discovery.
[21069141] Metallomics 2(2): 112-6 (2010)
2006  
10
Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects.
[16402138] Dalton Trans -(4): 529-41 (2006)
2010  
11
Exploring the cellular accumulation of metal complexes.
[20104335] Dalton Trans 39(5): 1159-70 (2010)
2007  
12
Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives.
[17680034] Dalton Trans -(32): 3474-82 (2007)
2007  
13
Ruthenium complexes can target determinants of tumour malignancy.
[17372640] Dalton Trans -(13): 1267-72 (2007)
2008  
14
Antitumour metal compounds: more than theme and variations.
[18097483] Dalton Trans -(2): 183-94 (2008)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Antineoplastic agents (Organometallic).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Antineoplastic agents (Organometallic).php on line 92